Buprenorphine: An anesthesia-centric review

Thomas Hickey; Gregory Acampora

doi:10.5055/jom.0901

Authors

Thomas Hickey, MD, MS https://orcid.org/0000-0003-4890-0238
Gregory Acampora, MD

DOI:

https://doi.org/10.5055/jom.0901

Keywords:

buprenorphine, perioperative, Suboxone®, acute pain, chronic pain, opioid adverse effects

Abstract

Buprenorphine was synthesized in the 1960s as a result of a search for a safe and effective opioid analgesic. Present formulations of buprenorphine are approved for the treatment of both acute and chronic pain. Its long duration of action, high affinity, and partial agonism at the μ-opioid receptor have established it as a mainstay treatment for opioid use disorder (OUD). Full agonist opioids (FAOs) remain a primary choice for perioperative pain in both opioid-naïve and opioid-tolerant patients despite well-known harms and new emphasis on multimodal analgesia strategies prioritizing nonopioid analgesics. We review the evidence supporting the use of buprenorphine as an effective analgesic alternative to more commonly prescribed FAOs in acute and chronic pain management. For the patient prescribed buprenorphine for OUD, prior conventionalism advised temporary discontinuation of buprenorphine preoperatively; this paradigm has shifted toward continuing buprenorphine throughout the perioperative period. Questions remain whether dose adjustments may improve patient outcomes.

Author Biographies

Thomas Hickey, MD, MS

Assistant Professor, Anesthesiology, Yale University School of Medicine; VA Connecticut Healthcare System, New Haven, Connecticut

Gregory Acampora, MD

Psychiatrist; Assistant Professor, Harvard Medical School; MGH/Harvard Center for Addiction Medicine, Massachusetts General Hospital; Addiction Leadership, Charlestown Community Health Care Center for Pain Management; HOME BASE Veterans and Family Care, Boston, Massachusetts

References

Ahmad FB, Cisewski JA, Rossen LM, et al.: Provisional drug overdose death counts. National Center for Health Statistics. 2023. Available at https://www.cdc.gov/nchs/nvss/vsrr/drugoverdose-data.htm. Accessed June 10, 2024.

Siglin J, Sorkin JD, Namiranian K: Incidence of postoperative opioid overdose and new diagnosis of opioid use disorder among US veterans. Am J Addict. 2020; 29(4): 295-304. DOI: 10.1111/ajad.13022.

NICE: Database of treatment effects. Available at https://www.nice.org.uk. Accessed March 2023.

Larochelle MR, Bernson D, Land T, et al.: Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. Ann Intern Med. 2018; 169: 137.

Chou R, Dana T, Blazina I, et al.: Interventions for unhealthy drug use—Supplemental report: A systematic review for the US preventive services task force [internet]. Report No.: 19-05255-EF-2. Rockville, MD: Agency for Healthcare Research and Quality, 2020.

Grande LA, Cundiff D, Greenwald MK, et al.: Evidence on buprenorphine dose limits: A review. J Addict Med. 2023; 17: 509-516. DOI: 10.1097/ADM.0000000000001189.10.1097/ADM.0000000000001189.

Olfson M, Zhang VS, Schoenbaum M, et al.: Trends in buprenorphine treatment in the US, 2009-2018. JAMA. 2020; 323: 276-277.

Harris LS: Problems of Drug Dependence, 1998 : Proceedings of the 60th Annual Scientific Meeting, the College on Problems of Drug Dependence, Inc. Bethesda, MD: US Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 1999: 7-13.

Volpe DA, McMahon Tobin GA, Daniel Mellon R, et al.: Uniform assessment and ranking of opioid μ receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol. 2011; 59(3): 385-390. DOI: 10.1016/j.yrtph.2010.12.007.

Avdeef A, Barrett DA, Shaw PN, et al.: Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates. J Med Chem. 1996; 39(22): 4377-4381.

Invidior Inc.: Subutex [package insert]. North Chesterfield, VA, USA. 2022.

Yassen A, Olofsen E, Romberg R, et al.: Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers. Anesthesiology. 2006; 104(6): 1232-1242.

Koppert W, Ihmsen H, Körber N, et al.: Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain. 2005; 118(1-2): 15-22.

Downing JW, Leary WP, White ES: Buprenorphine: A new potent long-acting synthetic analgesic. Comparison with morphine. Br J Anaesth. 1977; 49(3): 251-255.

Greenwald MK, Herring AA, Perrone J, et al.: A neuropharmacological model to explain buprenorphine induction challenges. Ann Emerg Med. 2022; 80(6): 509-524. DOI: 10.1016/j.annemergmed.2022.05.032.

Webster L, Gudin J, Raffa RB, et al.: Understanding buprenorphine for use in chronic pain: Expert opinion. Pain Med. 2020; 21(4): 714-723.

Coe MA, Lofwall MR, Walsh SL: Buprenorphine pharmacology review: Update on transmucosal and long-acting formulations. J Addict Med. 2019; 13(2): 93-103.

White LD, Hodge A, Vlok R, et al.: Efficacy and adverse effects of buprenorphine in acute pain management: Systematic review and meta-analysis of randomised controlled trials. Br J Anaesth. 2018; 120(4): 668-678.

Murray N, Malla U, Vlok R, et al.: Buprenorphine versus morphine in paediatric acute pain: A systematic review and meta-analysis. Crit Care Res Pract. 2018; 2018: 1-5. DOI: 10.1155/2018/3792043.

Raffa RB, Haidery M, Huang HM, et al.: The clinical analgesic efficacy of buprenorphine. J Clin Pharm Ther. 2014; 39(6): 577-583. DOI: 10.1111/jcpt.12196.

Harcus AH, Ward AE, Smith DW: Buprenorphine in postoperative pain: Results in 7500 patients. Anaesthesia. 1980; 35(4): 382-386. DOI: 10.1111/j.1365-2044.1980.tb05125.x.

Harcus AW, Ward AE, Smith DW: The monitored release of buprenorphine: Results in the young. J Int Med Res. 1980; 8(2): 153-155. DOI: 10.1177/030006058000800210.

Harcus AW, Ward AE, Smith DW: Buprenorphine: Experience in an elderly population of 975 patients during a year's monitored release. Int J Clin Practice. 1980; 34(5): 144-146.

Wong SSC, Chan TH, Wang F, et al.: Analgesic effect of buprenorphine for chronic noncancer pain: A systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2023; 137(1): 59-71. DOI: 10.1213/ANE.0000000000006467.

Lazaridou A, Paschali M, Edwards RR, et al.: Is buprenorphine effective for chronic pain? A systematic review and metaanalysis. Pain Med. 2020; 21(12): 3691-3699. DOI: 10.1093/pm/pnaa089.

Davis MP: Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol. 2012; 10(6): 209-219.

Derbel I, Ghorbel A, Akrout FM, et al.: Opiate withdrawal syndrome in buprenorphine abusers admitted to a rehabilitation center in Tunisia. Afr Health Sci. 2017; 16(4): 1067-1077. DOI: 10.4314/ahs.v16i4.24.

Hale M, Garofoli M, Raffa RB: Benefit-risk analysis of buprenorphine for pain management. J Pain Res. 2021; 14: 1359-1369. DOI: 10.2147/JPR.S305146.

Spreen LA, Dittmar EN, Quirk KC, et al.: Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review. Pharmacotherapy. 2022; 42(5): 411-427. DOI: 10.1002/phar.2676.

Kosel J, Bobik P, Tomczyk M: Buprenorphine—The unique opioid adjuvant in regional anesthesia. Expert Rev Clin Pharmacol. 2016; 9(3): 375-383. DOI: 10.1586/17512433.2016.1141047.

Vietor R, Kiendrebeogo R, Tracy E, et al.: Peripheral nerve block adjuncts: Which medication to choose? A narrative review of the current literature. Pain Manag. 2023; 13(11): 655-665. DOI: 10.2217/pmt-2023-0049.

Schubert AK, Seneviratne V, Stolz J, et al.: The effect of adjuvants added to local anaesthetics for single-injection upper extremity peripheral regional anaesthesia: A systematic review with network meta-analysis of randomised trials. Eur J Anaesthesiol. 2023; 40(9): 672-690. DOI: 10.1097/EJA.0000000000001860.

Kumar V, Kumar S, Bharti AK, et al.: Comparative study of efficacy of buprenorphine and fentanyl on attenuation of hemodynamic changes to laryngoscopy and intubation: A prospective, randomized double-blind study. Asian J Anesthesiol. 2022; 60(1): 26-32. DOI: 10.6859/aja.202203_60(1).0004.

Kay B: A double-blind comparison between fentanyl and buprenorphrine in analgesic-supplemented anaesthesia. Br J Anaesth. 1980; 52(4): 453-457. DOI: 10.1093/bja/52.4.453.

Tabuchi Y, Takahashi S: A comparison of fentanyl and buprenorphine in total intravenous anesthesia using propofol during spinal surgery. Masui. 2000; 49(7): 745-749.

Korttila K, Hovorka J: Buprenorphine as premedication and as analgesic during and after light isoflurane-N2O-O2 anaesthesia. A comparison with oxycodone plus fentanyl. Acta Anaesthesiol Scand. 1987; 31(8): 673-679. DOI: 10.1111/j.1399-6576.1987.tb02644.x.

Dahan A: Opioid-induced respiratory effects: New data on buprenorphine. Palliat Med. 2006; 20(Suppl. 1): s3-s8.

Webster LR, Hansen E, Cater J, et al.: A phase I placebo-controlled trial comparing the effects of buprenorphine buccal film and oral oxycodone hydrochloride administration on respiratory drive. Adv Ther. 2020; 37(11): 4685-4696. DOI: 10.1007/s12325-020-01481-0.

Walsh SL, Preston KL, Stitzer ML, et al.: Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clin Pharmacol Ther. 1994; 55(5): 569-580. DOI: 10.1038/clpt.1994.71.

Budd K: High dose buprenorphine for postoperative analgesia. Anaesthesia. 1981; 36(9): 900-903. DOI: 10.1111/j.1365-2044.1981.tb08867.x.

Moss LM, Algera MH, Dobbins R, et al.: Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients. PLoS One. 2022; 17(1): e0256752. DOI: 10.1371/journal.pone.0256752.

Tanz LJ, Jones CM, Davis NL, et al.: Trends and characteristics of buprenorphine-involved overdose deaths prior to and during the COVID-19 pandemic. JAMA Netw Open. 2023; 6(1): e2251856. DOI: 10.1001/jamanetworkopen.2022.51856.

John WS, Zhu H, Mannelli P, et al.: Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients. Drug Alcohol Depend. 2018; 187: 79-87. DOI: 10.1016/j.drugalcdep.2018.01.035.

Herring AA, Vosooghi AA, Luftig J, et al.: High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder. JAMA Netw Open. 2021; 4(7): e2117128. DOI: 10.1001/jamanetworkopen.2021.17128.

van Dorp E, Yassen A, Sarton E, et al.: Naloxone reversal of buprenorphine-induced respiratory depression. Anesthesiology. 2006; 105(1): 51-57. DOI: 10.1097/00000542-200607000-00012.

Bach P, Bawa M, Grant C, et al.: Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014-2020. Int J Drug Policy. 2022; 101: 103545. DOI: 10.1016/j.drugpo.2021.103545.

Cicero TJ, Ellis MS, Chilcoat HD: Understanding the use of diverted buprenorphine. Drug Alcohol Depend. 2018; 193: 117-123. DOI: 10.1016/j.drugalcdep.2018.09.007.

Buresh M, Ratner J, Zgierska A, et al.: Treating perioperative and acute pain in patients on buprenorphine: Narrative literature review and practice recommendations. J Gen Intern Med. 2020; 35(12): 3635-3643. DOI: 10.1007/s11606-020-06115-3.

Kohan L, Potru S, Barreveld AM, et al.: Buprenorphine management in the perioperative period: Educational review and recommendations from a multisociety expert panel. Reg Anesth Pain Med. 2021; 46(10): 840-859. DOI: 10.1136/rapm-2021-103007.

Mehta D, Thomas V, Johnson J, et al.: Continuation of buprenorphine to facilitate postoperative pain management for patients on buprenorphine opioid agonist therapy. Pain Phys. 2020; 23(2): E163-E174.

Quaye AN, Zhang Y: Perioperative management of buprenorphine: Solving the conundrum. Pain Med. 2019; 20(7): 1395-1408. DOI: 10.1093/pm/pny217.

Michigan Opioid Collaborative: Perioperative buprenorphine management: This protocol applies to all patients taking buprenorphine in the perioperative period regardless of indication. Available at https://michiganopioidcollaborative.org/wpcontent/uploads/2022/04/Perioperative-Bup-Mgmt-2019.pdf. Accessed July 26, 2024.

US Food and Drug Administration/Center for Drug Evaluation and Research: FDA clinical review on NDA 209819 for sublocade (buprenorphine) extended-release injection. 2017. Available at https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209819Orig1s000MedR.pdf. Accessed October 31, 2024.

Hickey TR, Henry JT, Edens EL, et al.: Perioperative management of extended-release buprenorphine. J Addict Med. 2022; 17(1): e67-e71. DOI: 10.1097/ADM.0000000000001024.

Hickey TR, Meeks T, Oxentine H, et al.: Perioperative management of extended-release buprenorphine: A narrative review and case series. Subst Abuse 2023; 44: 96-103. DOI: 10.1177/08897077231167043.

Braeburn, Inc: Brixadi. Package insert. 2023. Available a t https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210136Orig1s000lbl.pdf. Accessed October 31, 2024.

Arendt-Nielsen L, Andresen T, Malver LP, et al.: A double-blind, placebo-controlled study on the effect of buprenorphine and fentanyl on descending pain modulation: A human experimental study. Clin J Pain. 2012; 28(7): 623-627. DOI: 10.1097/AJP.0b013e31823e15cb.

Andresen T, Upton RN, Foster DJ, et al.: Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models. Basic Clin Pharmacol Toxicol. 2011; 108(4): 274-284. DOI: 10.1111/j.1742-7843.2010.00649.x.

Oifa S, Sydoruk T, White I, et al.: Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: A randomized, double-blind, four-arm trial in adults undergoing abdominal surgery. Clin Ther. 2009; 31(3): 527-541. DOI: 10.1016/j.clinthera.2009.03.018.

Dowell D, Ragan KR, Jones CM, et al.: CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep. 2022; 71: 1-95. DOI: 10.15585/mmwr.rr7103a1.

Sandbrink F, Murphy JL, Johansson M, et al.: VA/DoD guideline development group. The use of opioids in the management of chronic pain: Synopsis of the 2022 updated US Department of Veterans affairs and US Department of Defense Clinical Practice Guideline. Ann Intern Med. 2023; 176(3): 388-397. DOI: 10.7326/M22-2917.

Dahlhamer JM, Connor EM, Bose J, et al.: Prescription opioid use among adults with chronic pain: United States, 2019. Natl Health Stat Rep. 2021; 162: 1-9. DOI: 10.15620/cdc:107641.

Hovell BC, Ward AE: Pain relief in the post-operative period: A comparative trial of morphine and a new analgesic buprenorphine. J Int Med Res. 1973; 1(6): 417-421. DOI: 10.1177/030006057300100206.

US Department of Health and Human Services: Pain management best practices inter-agency task force report: Updates, gaps, inconsistencies, and recommendations. 2019. Available at https://www.hhs.gov/sites/default/files/pain-mgmt-bestpractices-draft-final-report-05062019.pdf. Accessed October 31, 2024.

BioDelivery Sciences International: Belbuca. Package insert. 2019. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207932s012lbl.pdf. Accessed October 31, 2024.

Purdue Pharma L.P.: Butrans. Package insert. 2022. Available at https://www.accessdata.fda.gov/spl/data/1f222930-a4c9-4557-ae1c-02f9b1368332/1f222930-a4c9-4557-ae1c-02f9b1368332.xml. Accessed October 31, 2024.

Bryson EO: The opioid epidemic and the current prevalence of substance use disorder in anesthesiologists. Curr Opin Anaesthesiol. 2018; 31(3): 388-392. DOI: 10.1097/ACO.0000000000000589.

Agniel D, Brat GA, Marwaha JS, et al.: Association of postsurgical opioid refills for patients with risk of opioid misuse and chronic opioid use among family members. JAMA Netw Open. 2022; 5(7): e2221316. DOI: 10.1001/jamanetworkopen.2022.21316.

Yang MMH, Hartley RL, Leung AA, et al.: Preoperative predictors of poor acute postoperative pain control: A systematic review and meta-analysis. BMJ Open. 2019; 9(4): e025091. DOI: 10.1136/bmjopen-2018-025091.

Kehlet H, Jensen TS, Woolf CJ: Persistent postsurgical pain: Risk factors and prevention. Lancet. 2006; 367(9522): 1618-1625. DOI: 10.1016/S0140-6736(06)68700-X.

Colvin LA, Bull F, Hales TG: Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia. Lancet. 2019; 393(10180): 1558-1568.

Meyer-Frießem CH, Lipke E, Weibel S, et al.: Perioperative ketamine for postoperative pain management in patients with preoperative opioid intake: A systematic review and meta-analysis. J Clin Anesth. 2022; 78: 110652. DOI: 10.1016/j.jclinane.2022.110652.

Chou R, Gordon DB, de Leon-Casasola OA, et al.: Management of postoperative pain: A clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016; 17(2): 131-157. DOI: 10.1016/j.jpain.2015.12.008.

Wyatt SA: Pain management in people who have OUD; acute vs. chronic pain [PowerPoint slides]. Carolinas HealthCare System. 2017.

Wyse JJ, Herreid-O'Neill A, Dougherty J, et al.: Perioperative management of buprenorphine/naloxone in a large, national health care system: A retrospective cohort study. J Gen Intern Med. 2022; 37(12): 2998-3004. DOI: 10.1007/s11606-021-07118-4.

Quaye A, Mardmomen N, Mogren G, et al.: Current state of perioperative buprenorphine management—A national provider survey. J Addict Med. 2023; 17: 640-645. DOI: 10.1097/ADM.0000000000001191.10.1097/ADM.0000000000001191.

Bogdanowicz KM, Stewart R, Chang CK, et al.: Excess overdose mortality immediately following transfer of patients and their care as well as after cessation of opioid substitution therapy. Addiction. 2018; 113(5): 946-951. DOI: 10.1111/add.14114.

McNicholas L: US Department of Health and Human Services (HHS). TIP 40: Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction: Treatment improvement protocol (TIP) series 40. Available at http://lib.adai.washington.edu/clearinghouse/downloads/TIP-40-Clinical-Guidelines-forthe-use-of-buprenorphine-in-the-treatment-of-Opioid-Addiction-54.pdf. Accessed September 7, 2023.

Dobkin AB, Esposito B, Philbin C: Double-blind evaluation of buprenorphine hydrochloride for post-operative pain. Canad Anaesth Soc J. 1977; 24(2): 195-202. DOI: 10.1007/BF03006232.

Hovell BC: Comparison of buprenorphine, pethidine and pentazocine for the relief of pain after operation. Br J Anaesth. 1977; 49(9): 913-916. DOI: 10.1093/bja/49.9.913.

Kay B: A double-blind comparison of morphine and buprenorphine in the prevention of pain after operation. Br J Anaesth. 1978; 50(6): 605-609. DOI: 10.1093/bja/50.6.605.

Kamel MM, Geddes IC: A comparison of buprenorphine and pethidine for immediate postoperative pain relief by the I.V. route. Br J Anaesth. 1978; 50(6): 599-603. DOI: 10.1093/bja/50.6.599.

Chakravarty K, Tucker W, Rosen M, et al.: Comparison of buprenorphine and pethidine given intravenously on demand to relieve postoperative pain. Br Med J. 1979; 2(6195): 895-897. DOI: 10.1136/bmj.2.6195.895.

Edge WG, Cooper GM, Morgan M: Analgesic effects of sublingual buprenorphine. Anaesthesia. 1979; 34(5): 463-467. DOI: 10.1111/j.1365-2044.1979.tb06325.x.

Fry EN: Relief of pain after surgery. A comparison of sublingual buprenorphine and intramuscular papaveretum. Anaesthesia. 1979; 34(6): 549-551. DOI: 10.1111/j.1365-2044.1979.tb06339.x.

Hayes MJ, Fraser AR, Hampton JR: Randomised trial comparing buprenorphine and diamorphine for chest pain in suspected myocardial infarction. Br Med J. 1979; 2(6185): 300-302. DOI: 10.1136/bmj.2.6185.300.

Tigerstedt I, Tammisto T: Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain. Acta Anaesthesiol Scand. 1980; 24(6): 462-468. DOI: 10.1111/j.1399-6576.1980.tb01584.x.

Masson AH: Sublingual buprenorphine versus oral dihydrocodeine in post-operative pain. J Int Med Res. 1981; 9(6): 506-510. DOI: 10.1177/030006058100900614.

Mok MS, Lippmann M, Steen SN: Multidose/observational, comparative clinical analgetic evaluation of buprenorphine. J Clin Pharmacol. 1981; 21(7): 323-329. DOI: 10.1002/j.1552-4604.1981.tb01774.x.

Wang RI, Johnson RP, Robinson N, et al.: The study of analgesics following single and repeated doses. J Clin Pharmacol. 1981; 21(2): 121-125. DOI: 10.1002/j.1552-4604.1981.tb01761.x.

Cook PJ, James IM, Hobbs KE, et al.: Controlled comparison of I.M. morphine and buprenorphine for analgesia after abdominal surgery. Br J Anaesth. 1982; 54(3): 285-290. DOI: 10.1093/bja/54.3.285.

Ellis R, Haines D, Shah R, et al.: Pain relief after abdominal surgery—A comparison of I.M. morphine, sublingual buprenorphine and self-administered I.V. pethidine. Br J Anaesth. 1982; 54(4): 421-428. DOI: 10.1093/bja/54.4.421.

Finlay IG, Scott R, McArdle CS: Prospective double-blind comparison of buprenorphine and pethidine in ureteric colic. Br Med J (Clin Res Ed). 1982; 284(6332): 1830-1831. DOI: 10.1136/bmj.284.6332.1830.

Ouellette RD: Buprenorphine and morphine efficacy in postoperative pain: A double-blind multiple-dose study. J Clin Pharmacol. 1982; 22(4): 165-172. DOI: 10.1002/j.1552-4604.1982.tb02158.x.

Harmer M, Slattery PJ, Rosen M, et al.: Intramuscular on demand analgesia: Double blind controlled trial of pethidine, buprenorphine, morphine, and meptazinol. Br Med J (Clin Res Ed). 1983; 286(6366): 680-682. DOI: 10.1136/bmj.286.6366.680.

Harmer M, Slattery PJ, Rosen M, et al.: Comparison between buprenorphine and pentazocine given I.V. on demand in the control of postoperative pain. Br J Anaesth. 1983; 55(1): 21-25. DOI: 10.1093/bja/55.1.21.

O'Sullivan G, Bullingham RE, McQuay HJ, et al.: A comparison of intramuscular and sublingual buprenorphine, intramuscular morphine and placebo as premedication. Anaesthesia. 1983; 38(10): 977-984. DOI: 10.1111/j.1365-2044.1983.tb12029.x.

Bradley JP: A comparison of morphine and buprenorphine for analgesia after abdominal surgery. Anaesth Intensive Care. 1984; 12(4): 303-310. DOI: 10.1177/0310057X8401200403.

Cuschieri RJ, Morran CG, McArdle CS: Comparison of morphine and sublingual buprenorphine following abdominal surgery. Br J Anaesth. 1984; 56(8): 855-859. DOI: 10.1093/bja/56.8.855.

Derbyshire DR, Vater M, Maile CI, et al.: Non-parenteral postoperative analgesia. A comparison of sublingual buprenorphine and morphine sulphate (slow release) tablets. Anaesthesia. 1984; 39(4): 324-328. DOI: 10.1111/j.1365-2044.1984.tb07271.x.

Ouellette RD: Comparison of analgesic activity of buprenorphine hydrochloride and morphine in patients with moderate to severe pain postoperatively. Surg Gynecol Obstet. 1984; 159(3): 201-206.

Pausawasdi S, Tontisirin O, Bunyaratavej S: A comparison of buprenorphine and morphine for immediate postoperative pain relief in Thai patients. J Med Assoc Thai. 1984; 67(5): 284-289.

Green DW, Sinclair JR, Mikhael MS: Buprenorphine versus morphine. A comparison of intra-operative and postoperative analgesia. Anaesthesia. 1985; 40(4): 371-375. DOI: 10.1111/j.1365-2044.1985.tb10793.x.

Risbo A, Chraemmer Jørgensen B, Kolby P, et al.: Sublingual buprenorphine for premedication and postoperative pain relief in orthopaedic surgery. Acta Anaesthesiol Scand. 1985; 29(2): 180-182. DOI: 10.1111/j.1399-6576.1985.tb02181.x.

Freedman M: A comparison of buprenorphine and pentazocine for the relief of postoperative pain. S Afr Med J. 1986; 69(1): 27-28.

Carl P, Crawford ME, Madsen NB, et al.: Pain relief after major abdominal surgery: A double-blind controlled comparison of sublingual buprenorphine, intramuscular buprenorphine, and intramuscular meperidine. Anesth Analg. 1986; 66(2): 142-146.

Payne KA, Murray WB, Barrett H: Intramuscular buprenorphine compared with morphine for postoperative analgesia. S Afr Med J. 1987; 71(6): 359-361.

Pugh GC, Drummond GB, Elton RA, et al.: Constant I.V. infusions of nalbuphine or buprenorphine for pain after abdominal surgery. Br J Anaesth. 1987; 59(11): 1364-1374. DOI: 10.1093/bja/59.11.1364.

Rabinov M, Rosenfeldt FL, McLean AJ: A double-blind comparison of the relative efficacy, side effects and cost of buprenorphine and morphine in patients after cardiac surgery. Aust N Z J Surg. 1987; 57(4): 227-232. DOI: 10.1111/j.1445-2197.1987.tb01345.x.

Maunuksela EL, Korpela R, Olkkola KT: Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain of children. Br J Anaesth. 1988; 60(1): 48-55. DOI: 10.1093/bja/60.1.48.

Maunuksela EL, Korpela R, Olkkola KT: Comparison of buprenorphine with morphine in the treatment of postoperative pain in children. Anesth Analg. 1988; 67(3): 233-239.

Ouellette RD: Double-blind, multiple-dose comparison of buprenorphine and meperidine for postoperative pain following major abdominal surgery. Curr Therap Res. 1989; 46(2): 352-365.

Tungphaisal S, Chandeying V, Sutthijumroon S, et al.: Sublingual buprenorphine and pethidine for immediate postoperative pain relief in major gynecologic surgery: A comparative study. J Med Assoc Thai. 1989; 72(3): 150-153.

Khan FA, Kamal RS: A comparison of buprenorphine and pethidine in analgesic supplemented anaesthesia. Singapore Med J. 1990; 31(4): 345-349.

Moa G, Zetterström H: Sublingual buprenorphine as postoperative analgesic: A double-blind comparison with pethidine. Acta Anaesthesiol Scand. 1990; 34(1): 68-71. DOI: 10.1111/j.1399-6576.1990.tb03044.x.

Laitinen J, Nuutinen L: Failure of transcutaneous electrical nerve stimulation and indomethacin to reduce opiate requirement following cholecystectomy. Acta Anaesthesiol Scand. 1991; 35(8): 700-705. DOI: 10.1111/j.1399-6576.1991.tb03375.x.

Lehmann KA, Grond S, Freier J, et al.: Postoperative pain management and respiratory depression after thoracotomy: A comparison of intramuscular piritramide and intravenous patient-controlled analgesia using fentanyl or buprenorphine. J Clin Anesth. 1991; 3(3): 194-201. DOI: 10.1016/0952-8180(91)90158-j.

Lejus C, Blanloeil Y, Francois T, et al.: Postoperative analgesia by continuous intravenous infusion in major abdominal surgery: Comparison of buprenorphine, fentanyl and nalbuphine. Ann Fran Anesth Reanim. 1991; 10(Suppl.): R67.

Dingus DJ, Sherman JC, Rogers DA, et al.: Buprenorphine versus morphine for patient-controlled analgesia after cholecystectomy. Surg Gynecol Obstet. 1993; 177(1): 1-6.

Hamunen K, Olkkola KT, Maunuksela EL: Comparison of the ventilatory effects of morphine and buprenorphine in children. Acta Anaesthesiol Scand. 1993; 37(5): 449-453. DOI: 10.1111/j.1399-6576.1993.tb03744.x.

Sidhu BS, Khichy S, Singh KH: Comparative evaluation of intramuscular buprenorphine, pentazocine and nefopam in postoperative pain relief. J Indian Med Assoc. 1993; 91(11): 288-289.

van den Berg AA, Honjol NM, Prabhu NV, et al.: Analgesics and ENT surgery. A clinical comparison of the intraoperative, recovery and postoperative effects of buprenorphine, diclofenac, fentanyl, morphine, nalbuphine, pethidine and placebo given intravenously with induction of anaesthesia. Br J Clin Pharmacol. 1994; 38(6): 533-543. DOI: 10.1111/j.1365-2125.1994.tb04395.x.

Olkkola KT, Leijala MA, Maunuksela EL: Paediatric ventilator effects of morphine and buprenorphine revisited. Paediatr Anaesth. 1995; 5(5): 303-305. DOI: 10.1111/j.1460-9592.1995.tb00311.x.

Gaitini L, Moskovitz B, Katz E, et al.: Sublingual buprenorphine compared to morphine delivered by a patient-controlled analgesia system as postoperative analgesia after prostatectomy. Urol Int. 1996; 57(4): 227-229. DOI: 10.1159/000282920.

Lejus C, Blanloeil Y, François T, et al.: Post-operative intravenous continuous analgesia: Comparison of buprenorphine, fentanyl and nalbuphine. Eur J Anaesthesiol. 1996; 13(1): 57-65. DOI: 10.1097/00003643-199601000-00011.

Ho ST, Wang JJ, Liu HS, et al.: The analgesic effect of PCA buprenorphine in Taiwan's gynecologic patients. Acta Anaesthesiol Sin. 1997; 35(4): 195-199.

Khan FA, Zaidi A, Kamal RS: Comparison of nalbuphine and buprenorphine in total intravenous anaesthesia. Anaesthesia. 1997; 52(11): 1095-1101. DOI: 10.1111/j.1365-2044.1997.211-az0347.x.

Lacoste L, Thomas D, Kraimps JL, et al.: Postthyroidectomy analgesia: Morphine, buprenorphine, or bupivacaine? J Clin Anesth. 1997; 9(3): 189-193. DOI: 10.1016/s0952-8180(97)00038-x.

Albrecht S, Fechner J, Geisslinger G, et al.: Postoperative pain control following remifentanil-based anaesthesia for major abdominal surgery. Anaesthesia. 2000; 55(4): 315-322. DOI: 10.1046/j.1365-2044.2000.01122.x.

Faridi MA, Shah SI, Bhatti AH, et al.: Postoperative analgesia; a comparison of sublingual buprenorphine and intramuscular morphine for pain relief after abdominal hysterectomy. Professional. 2004; 11(02): 152-157.

Chang KY, Chang WK, Chang WL, et al.: Comparison of intravenous patient-controlled analgesia with buprenorphine versus morphine after lumbar spinal fusion—A prospective randomized clinical trial. Acta Anaesthesiol Taiwan. 2006; 44(3): 153-159.

Jalili M, Fathi M, Moradi-Lakeh M, et al.: Sublingual buprenorphine in acute pain management: A double-blind randomized clinical trial. Ann Emerg Med. 2012; 59(4): 276-280. DOI: 10.1016/j.annemergmed.2011.10.021.

Setti T, Sanfilippo F, Leykin Y: Transdermal buprenorphine for postoperative pain control in gynecological surgery: A prospective randomized study. Curr Med Res Opin. 2012; 28(10): 1597-1608. DOI: 10.1185/03007995.2012.719864.

Alizadeh S, Mahmoudi GA, Solhi H, et al.: Post-operative analgesia in opioid dependent patients: Comparison of intravenous morphine and sublingual buprenorphine. Addict Health. 2015; 7(1-2): 60-65.

Payandemehr P, Jalili M, Mostafazadeh Davani B, et al.: Sublingual buprenorphine for acute renal colic pain management: A double-blind, randomized controlled trial. Int J Emerg Med. 2014; 7(1): 1-DOI: 10.1186/1865-1380-7-1.

Arshad Z, Prakash R, Gautam S, et al.: Comparison between transdermal buprenorphine and transdermal fentanyl for postoperative pain relief after major abdominal surgeries. J Clin Diagn Res. 2015; 9(12): UC01-4. DOI: 10.7860/JCDR/2015/16327.6917.

Rauck RL, Potts J, Xiang Q, et al.: Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain. Postgrad Med. 2016; 128(1): 1-11. DOI: 10.1080/00325481.2016.1128307.

Soltani G, Khorsand M, Shamloo AS, et al.: Comparison of intravenous morphine with sublingual buprenorphine in management of postoperative pain after closed reduction orthopedic surgery. Arch Bone Jt Surg. 2015; 3(4): 280-285.

Hosseininejad M, KhajeSamakoush A, Montazer H, et al.: Comparing the effects of sublingual buprenorphine and intravenous morphine on acute renal colic. J Mazandaran Univ Med Sci. 2016; 26: 1e10.

Kim HJ, Ahn HS, Nam Y, et al.: Comparative study of the efficacy of transdermal buprenorphine patches and prolonged-release tramadol tablets for postoperative pain control after spinal fusion surgery: A prospective, randomized controlled non-inferiority trial. Eur Spine J. 2017; 26(11): 2961-2968. DOI: 10.1007/s00586-017-5213-5.

Mercieri M, Palmisani S, De Blasi RA, et al.: Low-dose buprenorphine infusion to prevent postoperative hyperalgesia in patients undergoing major lung surgery and remifentanil infusion: A double-blind, randomized, active-controlled trial. Br J Anaesth. 2017; 119(4): 792-802. DOI: 10.1093/bja/aex174.

Niyogi S, Bhunia P, Nayak J, et al.: Efficacy of transdermal buprenorphine patch on post-operative pain relief after elective spinal instrumentation surgery. Indian J Anaesth. 2017; 61(11): 923-929. DOI: 10.4103/ija.IJA_118_17.

Londhe S, Patwardhan M, Shah R, et al.: Efficacy and safety of buprenorphine transdermal patch for immediate postoperative analgesia after total knee arthroplasty surgery. J Arthroplasty. 2020; 35(6S): S178-S181. DOI: 10.1016/j.arth.2020.02.015.

Bertona A, Bruchmann M, Rossi LA, et al.: Opioids against opioids. Buprenorphine transdermal patches in arthroscopic rotator cuff repair: Randomized controlled trial. In American Academy of Orthopaedic Surgeons Annual Meeting, August 31, 2021, San Diego, CA.

Khandelwal H, Negi A, Govil N, et al.: Comparative evaluation of analgesic efficacy of buprenorphine transdermal patch and fentanyl patch in management of postoperative pain after arthroscopic lower limb surgery: A randomized controlled trial. J Anaesthesiol Clin Pharmacol. 2021; 37(2): 272-278. DOI: 10.4103/joacp.JOACP_405_20.

Kiabi FH, Emadi SA, Shafizad M, et al.: The effect of preoperative sublingual buprenorphine on postoperative pain after lumbar discectomy: A randomized controlled trial. Ann Med Surg (Lond). 2021; 65: 102347. DOI: 10.1016/j.amsu.2021.102347.

Norozi V, Ghazi A, Amani F, et al.: Effectiveness of sublingual buprenorphine and fentanyl pump in controlling pain after open cholecystectomy. Anesth Pain Med. 2021; 11(3): e113909. DOI: 10.5812/aapm.113909.

Kauser D, Singh D: Comparisons of transdermal buprenorphine patch versus transdermal fentanyl patch for postoperative analgesia in lower limb orthopedic surgery. Indian J Public Health Res Dev. 2022; 13(3): 91-94.

Kirpichnikov A, Koto MZ, Ghoor F: Randomised controlled trial of intramuscular tramadol versus transdermal buprenorphine patch for early postoperative surgical pain. S Afr J Surg. 2022; 60(3): 160-166. DOI: 10.17159/2078-5151/SAJS3560.

Raizada N, Singh S, Singh G, et al.: Transdermal drug delivery system-future for post operative pain management—A study in post MRM patients. Int J Pharm Clin Res. 2022; 14(6): 586-590.

Shastri D, Patel I: RCT to compare analgesia property of USG-guided fascia iliaca block, IV fentanyl & sublingual tablet buprenorphine for positioning and postoperatively in fracture femur surgery under spinal anesthesia. IARS and SOCCA Abstracts. 2022: 705.

Dokku KS, Nair AS, Prasad Mantha SS, et al.: A randomized controlled study to compare analgesic efficacy of sublingual buprenorphine and intravenous tramadol in patients undergoing mastectomy. Med Gas Res. 2023; 13(3): 118-122. DOI: 10.4103/2045-9912.345170.